BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026)

Updated

BioAtla's Asset Utilization Ratio was 0.94 in Q2 2026, up 179.7% from 0.34 a year earlier.

Analysis

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at BioAtla came in at 0.06, down 52.8% from FY2024.

  • In earlier years, Asset Utilization Ratio was 0.13 in FY2024 and 0.00 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio in data going back to Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 0.62
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 0.49
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 0.47
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 0.52
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 0.46
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 0.51
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 0.40
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 0.58
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 0.31
10 BioAtla 2.49 Mn -16.45 Mn - 0.94
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.94
Dec 31, 2025 0.13
Sep 30, 2025 0.51
Jun 30, 2025 0.36
Dec 31, 2024 0.21
Sep 30, 2024 0.18
Jun 30, 2024 0.01
Sep 30, 2023 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
API Access

BioAtla Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BCAB&period=max&api_key=YOUR_API_KEY